Patents by Inventor Louwagie Joost

Louwagie Joost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF DETECTING COLORECTAL CANCER
    Publication number: 20120164238
    Abstract: A method of detecting a predisposition to, or the incidence of colorectal cancer in a faecal sample comprises, in a first step (a), detecting the presence of blood in the faecal sample, wherein detection of the presence of blood is indicative of a predisposition to, or the incidence of colorectal cancer. The method additionally comprises, in second step (b), detecting an epi-genetic modification in the DNA contained within the faecal sample, wherein detection of the epigenetic modification is indicative of a predisposition to, or the incidence of colorectal cancer. Based upon a positive result obtained in either (a) or (b) or in both (a) and (b) a predisposition to, or the incidence of colorectal cancer is detected. Related methods and kits involve detecting an epigenetic modification in a number of specific genes.
    Type: Application
    Filed: February 3, 2010
    Publication date: June 28, 2012
    Inventor: Louwagie Joost
  • Method for detection of drug-induced mutations in the reverse transcriptase gene
    Patent number: 6331389
    Abstract: The present invention relates to a method for the rapid and reliable detection of drug-induced mutations in the reverse transcriptase gene allowing the simultaneous characterization of a range of codons involved in drug resistance using specific sets of probes optimized to function together in a reverse-hybridization assay.
    Type: Grant
    Filed: May 30, 2000
    Date of Patent: December 18, 2001
    Assignee: Innogenetics N.V.
    Inventors: Stuyver Lieven, Louwagie Joost, Rossau Rudi
  • Method for detection of drug-induced mutations in the reverse transcriptase gene
    Patent number: 6087093
    Abstract: The present invention relates to a method for the rapid and reliable detection of drug-induced mutations in the reverse transcriptase gene allowing the simultaneous characterization of a range of codons involved in drug resistance using specific sets of probes optimized to function together in a reverse-hybridization assay.
    Type: Grant
    Filed: September 15, 1997
    Date of Patent: July 11, 2000
    Assignee: Innogenetics N.V.
    Inventors: Stuyver Lieven, Louwagie Joost, Rossau Rudi